A retrospective analysis of amputation rates in diabetic patients: Can lower extremity amputations be further prevented?

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Alvarsson, Alexandra ^a   Sandgren, Buster ^a   Wendel, Carl ^b   Alvarsson, Michael ^a   Brismar, Kerstin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Diabetic complications; Diabetic foot; Foot ulcer; Lower extremity amputations

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FOOT AMPUTATION; HIGH RISK PATIENT; HUMAN; INFECTION; KIDNEY DISEASE; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNIVERSITY HOSPITAL; VASCULAR DISEASE; AMPUTATION; COMPARATIVE STUDY; FOOT ULCER; LEG; MIDDLE AGED; SEXUAL DEVELOPMENT; SWEDEN;

AGED; AGED, 80 AND OVER; AMPUTATION; DIABETES COMPLICATIONS; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SWEDEN;

EID: 84857663546     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-18     Document Type: Article

References (54)

1. Matricali GA, Dereymaeker G, Muls E, Flour M, Mathieu C. Economic aspects of diabetic foot care in a multidisciplinary setting: a review. Diabetes/metabolism research and reviews 2007, 23:339-347. 10.1002/dmrr.706, 17103490.
2. Larsson J, Agardh CD, Apelqvist J, Stenström A. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 1998, 350:149-158.
3. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990, 13:513-521. 10.2337/diacare.13.5.513, 2351029.
4. Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. Diabetologia 2004, 47:2051-2058. 10.1007/s00125-004-1584-3, 15662547.
5. Sumpio BE. Foot Ulcers. N Engl J Med 2000, 343:787-793. 10.1056/NEJM200009143431107, 10984568.
6. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999, 22:1029-1035. 10.2337/diacare.22.7.1029, 10388962.
7. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006, 29:1288-1293. 10.2337/dc05-2425, 16732010.
8. Eggers PW, Gohdes D, Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 1999, 56:524-1533.
9. Anon Diabetes care and research in Europe: the St Vincent declaration. Diabet Med 1990, 7:360. Anon.
10. Spri in association with Swedish Medical Research Council Consensus statement. Foot problems of diabetics. Report No.: 329 1998, Spri Publications, Stockholm, Spri in association with Swedish Medical Research Council.
11. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot: International Working Group on the Diabetic Foot. Diabetes/metabolism research and reviews 2000, 16(Suppl 1):S84-S92.
12. Jonasson JM, Ye W, Sparén P, Apelqvist J, Nyrén O, Brismar K. Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 2008, 31:1536-1540. 10.2337/dc08-0344, 2494662, 18443192.
13. Larsson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?. Diabet Med 1995, 12:770-776. 10.1111/j.1464-5491.1995.tb02078.x, 8542736.
14. Chen HF, Ho CA, Li CY. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 2006, 29:2409-2414. 10.2337/dc06-1343, 17065676.
15. Kärvestedt L. Progressive elements in type 2 diabetes, studies on secondary failure and diabetic complications. PhD Thesis 2009, Karolinska Institutet, Stockholm, Sweden, ISBN-978-91 7409-287-5.
16. SCB: Statistics Sweden. , http://www.scb.se/Pages/GsaSearch____287280.aspx
17. Larsson J, Eneroth M, Apelqvist J, Stenström A. Sustained reduction in major amputations in diabetic patients: 628 amputations in 461 patients in a defined population over a 20-year period. Acta Orthopaedica 2008, 79:665-673. 10.1080/17453670810016696, 18839374.
18. Canavan RJ, Unwin NC, Kelly WF, Connolly VM. Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care: continuous longitudinal monitoring using a standard method. Diabetes Care 2008, 31:459-463.
19. Krishnan S, Nash F, Baker N, Fowler D, Rayman G. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008, 31:99-101.
20. Ghanassia E, Villon L. Thuan Dit Dieudonné JF, Boegner C, Avignon A, Sultan A: Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care 2008, 31:1288-1292. 10.2337/dc07-2145, 2453665, 18390801.
21. Van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K. Reduction in Diabetes-Related Lower-Extremity Amputations in the Netherlands: 1991-2000. Diabetes Care 2004, 27:1042-1046. 10.2337/diacare.27.5.1042, 15111518.
22. Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999, 22:951-959. 10.2337/diacare.22.6.951, 10372248.
23. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999, 22:1036-1042. 10.2337/diacare.22.7.1036, 10388963.
24. Ashworth JJ, Smyth JV, Pendleton N, Horan M, Payton A, Worthington J, Ollier WE, Ashcroft GS. Polymorphisms spanning the 0 N exon and promoter of the estrogen receptor-beta (ERbeta) gene ESR2 are associated with venous ulceration. Clin Genet 2008, 73:55-61.
25. Ashworth JJ, Smyth JV, Pendleton N, Horan M, Payton A, Worthington J, Ollier WE, Ashcroft GS. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J Steroid Biochem Mol Biol 2005, 97:266-270. 10.1016/j.jsbmb.2005.05.012, 16153823.
26. Gilliver SC, Ashcroft GS. Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 2007, 10:276-288. 10.1080/13697130701456630, 17653954.
27. Ashcroft GS, Mills SJ. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 2002, 110:615-624. 151108, 12208862.
28. Malay DS, Margolis DJ, Hoffstad OJ, Bellamy S. The incidence and risks of failure to heal after lower extremity amputation for the treatment of diabetic neuropathic foot ulcer. J Foot Ankle Surg 2006, 45:366-374. 10.1053/j.jfas.2006.08.002, 17145461.
29. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1998, 21:2161-2177. 10.2337/diacare.21.12.2161, 9839111.
30. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ERE, Whalley AM, Widdows P, Williamson S, Boulton AJM. The North-West Diabetes Foot Care Study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002, 19:377-384.
31. NDR: National Diabetes Register, Årsrapport - 2009 års resultat. , https://www.ndr.nu/pdf/Arsrapport_NDR_2010.pdf
32. Ostman J, Lönnberg G, Arnqvist HJ, Blohmé G, Bolinder J, Ekbom Schnell A, Eriksson JW, Gudbjörnsdottir S, Sundkvist G, Nyström L. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002. J Intern Med 2008, 263:386-394. 10.1111/j.1365-2796.2007.01896.x, 18205768.
33. The National Board of Health and Welfare: Folkhälsa - Lägesrapport 2006. 2008, , http://www.socialstyrelsen.se
34. NDR: National Diabetes Register. , https://www.ndr.nu/NDR2/Default.aspx
35. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Expert Panel on Detection.
36. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176. 10.2337/diacare.28.1.164, 15616252.
37. Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008, 31:1331-1336. 10.2337/dc07-2244, 2453658, 18390800.
38. Papanas N, Liakopoulos V, Maltezos E, Stefanidis I. The diabetic foot in end stage renal disease. Ren Fail 2007, 29:519-528. 10.1080/08860220701391662, 17654312.
39. Morbach S, Quante C, Ochs HR, Gaschler F, Pallast JM, Knevels U. Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. Diabetes Care 2001, 24:1689-1690. 10.2337/diacare.24.9.1689, 11522723.
40. Lipscombe J, Jassal SV, Bailey S, Bargman JM, Vas S, Oreopoulos DG. Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003, 23:255-259.
41. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003, 26:491-494. 10.2337/diacare.26.2.491, 12547887.
42. Hosler AS, Melnik TA. Language and other factors associated with foot self-management among Puerto Ricans with diabetes in New York City. Diabetes Care 2006, 29:704-706. 10.2337/diacare.29.03.06.dc05-1659, 16505532.
43. Karter AJ, Stevens MR, Brown AF, Duru OK, Gregg EW, Gary TL, Beckles GL, Tseng CW, Marrero DG, Waitzfelder B, Herman WH, Piette JD, Safford MM, Ettner SL. Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. BMC Publ Health 2007, 7:308.
44. Cabezas-Cerrato J. The prevalence of diabetic neuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia 1998, 41:1263-1269. 10.1007/s001250051063, 9833931.
45. Dyck PJ, Katz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ, Service FJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
46. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993, 36:150-154. 10.1007/BF00400697, 8458529.
47. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, Ward JD, Boulton AJ. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994, 11:480-484. 10.1111/j.1464-5491.1994.tb00310.x, 8088127.
48. Thomas PK. Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur Neurol 1999, 41:35-43. 10.1159/000052078, 10023127.
49. Boulton AJM, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM, Skyler JS, Sosenko JM. Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986, 3:335-337. 10.1111/j.1464-5491.1986.tb00775.x, 2949922.
50. Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabet Med 1995, 12:36-41.
51. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001, 44:1973-1988. 10.1007/s001250100001, 11719828.
52. Steinhoff M, Sander S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003, 139:1479-1488. 10.1001/archderm.139.11.1479, 14623709.
53. Shepherd AJ, Downing JE, Miyan JA. Without nerves, immunology remains incomplete -in vivo veritas. Immunology 2005, 116:145-163. 10.1111/j.1365-2567.2005.02223.x, 1817817, 16162264.
54. Virkkunen J, Heikkinen M, Lepäntalo M, Metsänoja R, Salenius J, . Finnvasc Study Group Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 2004, 40:761-767. 10.1016/j.jvs.2004.07.040, 15472606, Finnvasc Study Group.